Literature DB >> 17264842

The met(158) allele of catechol-O-methyltransferase (COMT) is associated with obsessive-compulsive disorder in men: case-control study and meta-analysis.

E C Pooley1, N Fineberg, P J Harrison.   

Abstract

Existing data suggest a genetic association between the met(158) allele of catechol-O-methyltransferase (COMT) and obsessive-compulsive disorder (OCD). However, the results are inconclusive and complicated by possible gender differences. We sought to resolve the question in two ways. First, we carried out a new case-control study in 87 adults with OCD and 327 healthy comparison subjects. The study replicated reports of an increased met(158) allele frequency in men with OCD (odds ratio (OR)=1.91, 95% confidence interval (CI) 1.07-3.40, P=0.026), with no effect in women (OR=1.13, 95% CI 0.74-1.72, P=0.56). Second, we performed a meta-analysis of all published case-control data (n=1908 subjects). This revealed an association of COMT met(158) with OCD (OR=1.23, 95% CI 1.06-1.42, P=0.005) and an interaction with gender (z=4.27, P<0.0001). The association between COMT met(158) and OCD was present in men (OR=1.88, 95% CI 1.45-2.44, P<0.001) but not in women (OR=0.98, 95% CI 0.78-1.22, P=0.83). We conclude that COMT may play a role in the genetic aetiology of OCD in men. The biological plausibility of the association is increased by the functionality of the val(158)met polymorphism in terms of its effect on COMT enzyme activity, and by the role of COMT in cortical dopamine signalling and information processing. The finding also extends the evidence for sexual dimorphism in COMT and in OCD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17264842     DOI: 10.1038/sj.mp.4001951

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  52 in total

Review 1.  22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia.

Authors:  Maria Karayiorgou; Tony J Simon; Joseph A Gogos
Journal:  Nat Rev Neurosci       Date:  2010-06       Impact factor: 34.870

Review 2.  Genetics of obsessive-compulsive disorder and related disorders.

Authors:  Heidi A Browne; Shannon L Gair; Jeremiah M Scharf; Dorothy E Grice
Journal:  Psychiatr Clin North Am       Date:  2014-07-23

Review 3.  Translational approaches to obsessive-compulsive disorder: from animal models to clinical treatment.

Authors:  N A Fineberg; S R Chamberlain; E Hollander; V Boulougouris; T W Robbins
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 4.  Rodent models of obsessive compulsive disorder: Evaluating validity to interpret emerging neurobiology.

Authors:  Isaac Zike; Tim Xu; Natalie Hong; Jeremy Veenstra-VanderWeele
Journal:  Neuroscience       Date:  2016-09-16       Impact factor: 3.590

5.  Antisaccade performance in patients with obsessive-compulsive disorder and unaffected relatives: further evidence for impaired response inhibition as a candidate endophenotype.

Authors:  Leonhard Lennertz; Friederike Rampacher; Andrea Vogeley; Svenja Schulze-Rauschenbach; Ralf Pukrop; Stephan Ruhrmann; Joachim Klosterkötter; Wolfgang Maier; Peter Falkai; Michael Wagner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-03-23       Impact factor: 5.270

6.  Gonadectomy and hormone replacement exert region- and enzyme isoform-specific effects on monoamine oxidase and catechol-O-methyltransferase activity in prefrontal cortex and neostriatum of adult male rats.

Authors:  B Meyers; A D'Agostino; J Walker; M F Kritzer
Journal:  Neuroscience       Date:  2009-11-10       Impact factor: 3.590

7.  Catechol-O-methyltransferase val158met genotype determines effect of reboxetine on emotional memory in healthy male volunteers.

Authors:  Ayana A Gibbs; Carla E Bautista; Florence D Mowlem; Kris H Naudts; Dora T Duka
Journal:  J Psychiatry Neurosci       Date:  2014-05       Impact factor: 6.186

Review 8.  Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity.

Authors:  Dennis L Murphy; Pablo R Moya; Meredith A Fox; Liza M Rubenstein; Jens R Wendland; Kiara R Timpano
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-25       Impact factor: 6.237

9.  Dopamine and inhibitory action control: evidence from spontaneous eye blink rates.

Authors:  Lorenza Serena Colzato; Wery P M van den Wildenberg; Nelleke C van Wouwe; Merel M Pannebakker; Bernhard Hommel
Journal:  Exp Brain Res       Date:  2009-05-31       Impact factor: 1.972

10.  Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder.

Authors:  Jonathan T Ting; Guoping Feng
Journal:  Curr Chem Genomics       Date:  2008-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.